Open Label, Multicenter, Phase II Study Evaluating the Efficacy and Safety of IMC-11F8 in Combination With 5-FU/FA and Oxaliplatin (mFOLFOX-6) in Patients With Treatment-naive, Locally-Advanced or Metastatic Colorectal Cancer.
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2016
At a glance
- Drugs Necitumumab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 14 Jan 2016 Results published in the British Journal of Cancer
- 14 Dec 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.